Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): Complete Statistical AnalysisIndependent statistical analysis of Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): primary endpoint results, effect estimate with…
- Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01113385).
- Oral Health Educational Methods in Adolescence: Complete Statistical AnalysisIndependent statistical analysis of Oral Health Educational Methods in Adolescence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03216746).
- Oral Health Literacy and Oral Education: Complete Statistical AnalysisIndependent statistical analysis of Oral Health Literacy and Oral Education: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02436811).
- Oral Health Literacy Tailored Communication: Complete Statistical AnalysisIndependent statistical analysis of Oral Health Literacy Tailored Communication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01118143).
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD): Complete Statistical AnalysisIndependent statistical analysis of Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03028350).
- Oral Immunotherapy for Peanut and Mammalian Meat Allergies: Complete Statistical AnalysisIndependent statistical analysis of Oral Immunotherapy for Peanut and Mammalian Meat Allergies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02350660).
- Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): Complete Statistical AnalysisIndependent statistical analysis of Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oral Ketorolac for Arthroscopic Rotator Cuff Repair: Complete Statistical AnalysisIndependent statistical analysis of Oral Ketorolac for Arthroscopic Rotator Cuff Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03967847).
- Oral LAT8881 in Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of Oral LAT8881 in Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03865953).
- Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): Complete Statistical AnalysisIndependent statistical analysis of Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04409041).
- Oral Nifedipine Versus Oral Labetalol: Complete Statistical AnalysisIndependent statistical analysis of Oral Nifedipine Versus Oral Labetalol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02168309).
- Oral OKT3 for the Treatment of Active Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Oral OKT3 for the Treatment of Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01287195).
- Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis: Complete Statistical AnalysisIndependent statistical analysis of Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03425396).
- Oral ONC201 in Adult Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Oral ONC201 in Adult Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02525692).
- Oral ONC201 in Relapsed/Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Oral ONC201 in Relapsed/Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02863991).
- Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: Complete Statistical AnalysisIndependent statistical analysis of Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Oral Paricalcitol in Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Oral Paricalcitol in Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00587158).
- Oral Pathology Asynchronous Telementoring Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Oral Pathology Asynchronous Telementoring Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04166214).
- Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001596).
- Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495374).
- Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia: Complete Statistical AnalysisIndependent statistical analysis of Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oral Propionate to Treat and Prevent Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Oral Propionate to Treat and Prevent Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01692002).
- Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps: Complete Statistical AnalysisIndependent statistical analysis of Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02927834).
- ORAL STRATEGYIndependent statistical analysis of An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women: Complete Statistical AnalysisIndependent statistical analysis of Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma: Complete Statistical AnalysisIndependent statistical analysis of Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00301418).
- Oral Testosterone for the Treatment of Hypogonadism: Complete Statistical AnalysisIndependent statistical analysis of Oral Testosterone for the Treatment of Hypogonadism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01717768).
- Oral Topotecan to Treat Recurrent or Persistent Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Oral Topotecan to Treat Recurrent or Persistent Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00382733).
- Oral Versus Intravenous Sedation for Ocular Procedures: Complete Statistical AnalysisIndependent statistical analysis of Oral Versus Intravenous Sedation for Ocular Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03246724).
- Oral Versus Intravenous Tranexamic Acid: Complete Statistical AnalysisIndependent statistical analysis of Oral Versus Intravenous Tranexamic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04089865).
- Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01856712).
- Oral vs. Intravenous TXA Study Proposal: TJA: Complete Statistical AnalysisIndependent statistical analysis of Oral vs. Intravenous TXA Study Proposal: TJA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02233101).
- Oral Zinc for the Treatment of Acute Diarrhea in US Children: Complete Statistical AnalysisIndependent statistical analysis of Oral Zinc for the Treatment of Acute Diarrhea in US Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ORANGEIndependent statistical analysis of Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03717935).
- OrBITIndependent statistical analysis of Overactive Bladder Innovative Therapy Trial (OrBIT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00448175).
- ORBIT IIIndependent statistical analysis of Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORCA-V1Independent statistical analysis of A Study of Cytisinicline for Vaping Cessation in Adult Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05431387).
- ORCHARRDIndependent statistical analysis of Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- Orchestra Pregnancy Observational Study in Poland: Complete Statistical AnalysisIndependent statistical analysis of Orchestra Pregnancy Observational Study in Poland: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01779141).
- OReOIndependent statistical analysis of A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705): Complete Statistical AnalysisIndependent statistical analysis of Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Organizational Skills Training – Tier 2 (OST-T2): Complete Statistical AnalysisIndependent statistical analysis of Organizational Skills Training - Tier 2 (OST-T2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03443323).
- ORIENT-1Independent statistical analysis of Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ORIGAMAIndependent statistical analysis of Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ORIONIndependent statistical analysis of A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ORIONIndependent statistical analysis of EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORION-1Independent statistical analysis of Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ORION-10Independent statistical analysis of Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…